Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro (Q40176252)
scientific article published on February 2007
Language:
Current Data About Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro
(P31) (Q13442814)
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P50) (Q38290301)
(P1545) 2
(P1932) Judy Dering

(P304) 319-326
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P407) (Q1860)

(P433) 3
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P478) 105
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P577) Thursday, February 1, 2007
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P921) (Q27139135)
(P887)

(Q419940)
(P887)

(P1433) (Q326085)
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P1476) "Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro" (language: en)
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

(P2093) Richard S Finn
(P1545) 1
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

Charles Ginther
(P1545) 3
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

Cindy A Wilson
(P1545) 4
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

Padraic Glaspy
(P1545) 5
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

Nishan Tchekmedyian
(P1545) 6
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

Dennis J Slamon
(P1545) 7
(P248)
(P698) 17268817
(P813) Monday, September 18, 2017

other details
description scientific article published on February 2007

External Links
(P356) 10.1007/S10549-006-9463-X
(P698) 17268817
(P5875) 6535478
(P6179) 1041402709